ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Biotechnol Biomater,

CRISPR-Cas9: Revolutionizing Genetic Modification in Biotechnology

Oluwafemi Belay*
Department of Microbiology, School of Data Science and Computational Thinking, Stellenbosch University, South Africa
*Corresponding Author : Oluwafemi Belay, Department of Microbiology, School of Data Science and Computational Thinking, Stellenbosch University, South Africa, Email: oluwafemibelayrush@gmail.com

Received Date: May 02, 2024 / Published Date: May 27, 2024

Abstract

CRISPR-Cas9 has emerged as a transformative tool in biotechnology, revolutionizing genetic modification with its precision and versatility. Originating from bacterial immune systems, CRISPR-Cas9 allows targeted modifications to genomic DNA, enabling applications ranging from gene editing in biomedical research to enhancing agricultural traits. This article explores the evolution, mechanisms, applications, implications, and future prospects of CRISPR-Cas9, highlighting its pivotal role in advancing biotechnological innovation.

Citation: Belay O (2024) CRISPR-Cas9: Revolutionizing Genetic Modification inBiotechnology. J Biotechnol Biomater, 14: 387.

Copyright: © 2024 Belay O. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top